BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19583480)

  • 1. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.
    Bahn RS; Burch HS; Cooper DS; Garber JR; Greenlee CM; Klein IL; Laurberg P; McDougall IR; Rivkees SA; Ross D; Sosa JA; Stan MN
    Thyroid; 2009 Jul; 19(7):673-4. PubMed ID: 19583480
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.
    Cooper DS
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3474-81. PubMed ID: 12915620
    [No Abstract]   [Full Text] [Related]  

  • 3. Antithyroid drugs.
    Cooper DS
    N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
    [No Abstract]   [Full Text] [Related]  

  • 4. Ending propylthiouracil-induced liver failure in children.
    Rivkees SA; Mattison DR
    N Engl J Med; 2009 Apr; 360(15):1574-5. PubMed ID: 19357418
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug therapy of Basedow's disease].
    Ishii J
    Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):868-72. PubMed ID: 1700042
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of methimazole and propylthiouracil in the management of children and adolescents with Graves' disease: efficacy and adverse reactions during initial treatment and long-term outcome.
    Sato H; Minagawa M; Sasaki N; Sugihara S; Kazukawa I; Minamitani K; Wataki K; Konda S; Inomata H; Sanayama K; Kohno Y
    J Pediatr Endocrinol Metab; 2011; 24(5-6):257-63. PubMed ID: 21823520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which anti-thyroid drug?
    Cooper DS
    Am J Med; 1986 Jun; 80(6):1165-8. PubMed ID: 3755286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The propylthiouracil dilemma.
    Glinoer D; Cooper DS
    Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W; Zhang J; Zhan Z; Xu B; Jin H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves' disease during pregnancy: a problem revisited.
    Gallagher MP; Schachner HC; Levine LS; Fisher DA; Berdon WE; Oberfield SE
    J Pediatr; 2001 Dec; 139(6):896-900. PubMed ID: 11743522
    [No Abstract]   [Full Text] [Related]  

  • 13. Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease: cross-reaction between propylthiouracil and methimazole.
    Ahmed K; Rao S; Simha V
    Endocr Pract; 2010; 16(3):449-51. PubMed ID: 20061292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
    Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on the medical treatment of Graves' hyperthyroidism.
    Marinò M; Latrofa F; Menconi F; Chiovato L; Vitti P
    J Endocrinol Invest; 2014 Nov; 37(11):1041-8. PubMed ID: 25185644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe pancytopenia associated with antithyroid drugs in a patient with Graves' disease and chronic renal failure.
    Macia M; Méndez M; Fernández J; Riverol A; Rios
    Clin Nephrol; 1997 Feb; 47(2):129. PubMed ID: 9049463
    [No Abstract]   [Full Text] [Related]  

  • 18. Propylthiouracil for hyperthyroidism.
    Med Lett Drugs Ther; 2009 Jul; 51(1317):57. PubMed ID: 19636289
    [No Abstract]   [Full Text] [Related]  

  • 19. Putting propylthiouracil in perspective.
    Cooper DS; Rivkees SA
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1881-2. PubMed ID: 19401361
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithyroid drug treatment for graves' disease in children: a long-term retrospective study at a single institution.
    Ohye H; Minagawa A; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Suzuki M; Yoshihara A; Ito K; Ito K
    Thyroid; 2014 Feb; 24(2):200-7. PubMed ID: 23926918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.